Cresset is a leading provider of innovative solutions for the digitization of drug discovery. Molab.ai (now known as Cresset AI ADME) is a division of Cresset, pioneering in artificial intelligence technologies tailored for molecular research. If you are interested in collaborating with or contributing to a purpose-driven AI company that combines scientific excellence, impact orientation and entrepreneurial drive, come join us on our journey!
| Website | https://cresset-group.com/software/ai-adme/ |
| Revenue | $18.2 million |
| Employees | 2 (2 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular molab.ai employee's phone or email?
The molab.ai annual revenue was $18.2 million in 2026.
Rebecca Scutt is the Managing Director of molab.ai.
2 people are employed at molab.ai.